The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac ageing.

This laboratory study investigated how heart aging occurs at the cellular level, specifically examining changes in blood vessel cells within the heart. Researchers studied mice with modified genes related to a protein called Ets2, which appears to play an important role in keeping the heart's blood vessels healthy as we age.

The scientists discovered that as hearts age, levels of Ets2 protein decrease in the cells lining blood vessels (endothelial cells). When Ets2 levels are low, these vessel cells undergo a harmful transformation where they change from their normal form into scar-forming cells, a process called endothelial-to-mesenchymal transition (EndoMT). This transformation contributes to heart scarring (fibrosis), stiffness, and dysfunction—all common problems in aging hearts.

Using advanced genetic techniques, the research team found that mice lacking normal Ets2 activity showed accelerated heart aging, including increased scarring and reduced heart function. They determined that Ets2 works by controlling other genes that keep blood vessel cells healthy and preventing them from becoming senescent (aged and dysfunctional cells that release inflammatory substances).

While this is fundamental cardiovascular research without direct connection to acupuncture, understanding the mechanisms of heart aging may eventually inform integrative approaches to cardiovascular health. The study identifies potential targets for future therapies aimed at preserving heart function during aging. Patients interested in supporting cardiovascular health through acupuncture or other complementary approaches should discuss options with their healthcare team. If considering acupuncture as part of a comprehensive heart health strategy, seek treatment from a licensed acupuncturist with experience in cardiovascular conditions.

This study utilized single-nucleus RNA sequencing and genetic mouse models to investigate Ets2's role in cardiac aging and endothelial-to-mesenchymal transition (EndoMT). Researchers generated Ets2-super-enhancer-deficient mice and endothelial cell-specific Ets2 knockout mice (ECKO), demonstrating that decreased Ets2 expression in cardiac endothelial cells correlates with accelerated cardiac aging phenotypes, including increased fibrosis and dysfunction. Mechanistic investigations revealed that Ets2 transcriptionally regulates TIE1, an endothelial marker gene, and its silencing promotes EndoMT, endothelial senescence, and activation of senescence-associated secretory phenotype (SASP), partially mediated by Serpine1. The study identifies a super-enhancer regulatory element controlling Ets2 expression in cardiac tissue. Clinical relevance: This research elucidates molecular mechanisms underlying cardiovascular aging, specifically the EndoMT pathway contributing to cardiac fibrosis. While this is fundamental research without immediate clinical applications or connection to acupuncture interventions, it identifies potential therapeutic targets for age-related cardiovascular pathology. No sample sizes, effect sizes, or human clinical data were provided in this basic science investigation.